Lensar (LNSR) Other Non-Current Liabilities (2019 - 2026)
Lensar's (LNSR) quarterly Other Non-Current Liabilities came in at $815000.0 in Q1 2026, up 32.31% year-on-year from $616000.0 in Q1 2025, and down 10.34% on a QoQ basis from $909000.0 in Q4 2025.
Lensar (LNSR) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Other Non-Current Liabilities data on file, last reported at $815000.0 in Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 32.31% year-over-year to $815000.0 in Q1 2026; TTM through Mar 2026 was $815000.0, a 32.31% increase from a year earlier, with the FY2025 full-year figure at $909000.0, down 96.96% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $815000.0, down from $909000.0 in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for LNSR reached as high as $47.2 million in Q2 2025 and fell as low as $52000.0 in Q1 2022.
- Historically, Other Non-Current Liabilities has averaged $7.4 million across 5 years, with a median of $715500.0 in 2025.
- On a YoY basis, Other Non-Current Liabilities climbed as much as 17929.77% in 2025 and fell as far as 96.96% in 2025.
- Year by year, Other Non-Current Liabilities stood at $167000.0 in 2022, then surged by 4964.07% to $8.5 million in 2023, then surged by 253.03% to $29.9 million in 2024, then plunged by 96.96% to $909000.0 in 2025, then declined by 10.34% to $815000.0 in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $815000.0 in Q1 2026, $909000.0 in Q4 2025, and $911000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Lensar | 70.05 Mn | 72.73 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 815,000.00 |
| Dec 31, 2025 | 909,000.00 |
| Sep 30, 2025 | 911,000.00 |
| Jun 30, 2025 | 47.24 Mn |
| Mar 31, 2025 | 616,000.00 |
| Dec 31, 2024 | 29.86 Mn |
| Sep 30, 2024 | 12.30 Mn |
| Jun 30, 2024 | 262,000.00 |
| Mar 31, 2024 | 537,000.00 |
| Dec 31, 2023 | 8.46 Mn |
| Sep 30, 2023 | 560,000.00 |
| Jun 30, 2023 | 568,000.00 |
| Dec 31, 2022 | 167,000.00 |
| Mar 31, 2022 | 52,000.00 |
| Dec 31, 2021 | 69,000.00 |
| Sep 30, 2021 | 90,000.00 |
| Jun 30, 2021 | 72,000.00 |
| Mar 31, 2021 | 97,000.00 |
| Dec 31, 2020 | 129,000.00 |
| Sep 30, 2020 | 51,000.00 |